Shionogi & Co., Ltd. engages in the manufacture and sale of pharmaceutical products, diagnostics, and other related products. The Company specializes in three product areas related to cardiovascular and metabolic diseases; infectious diseases and imm…
Analysis
Bargain bin
Shionogi & Co., Ltd. falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.
The price is attractive. You pay 10.1× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -3% yearly growth; analysts expect 10%. The price, in other words, assumes less than the experts do.
The trajectory is moderate and the balance sheet is adequate. The company scores 14/20 on our value-creation score: strong value creator.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202399
94
2023202420252026
All-time high
99
Jan 2023
All-time low
53
Jan 2024
Average rank
82
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
44
22
19
22
Price/Earnings
57
83
79
69
Price/Book
65
52
53
52
Dividend Yield
95
70
58
62
Value (overall)
88
58
50
49
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.